February 26, 2020

Intouch Execs Talk Key Pharma Marketing Issues for 2020

Image of two black women talking in office setting

It’s time again for Med Ad News’ annual agenda edition, and this year, industry thought leaders, including four executives from Intouch’s leadership team, lent their expertise to answer pressing concerns on pharma marketers’ minds, including data — data collection, data analysis, and of course, data privacy and security. As Intouch EVP Wendy Blackburn put it,

Pharma marketers and their agencies should continue to seek to harness the power of data — the opportunities are endless. But they must also build in data security from the beginning; eliminate loopholes; team up with knowledgeable partners; and remain ever-vigilant to keep their valuable data safe and secure.

Along with Blackburn, Intouch founder and CEO Faruk Capan, David Windhausen, EVP and president of Intouch B2D, and Aaron Uydess, EVP of customer experience and analytics, shared thoughts on how U.S politics, the upcoming national election and current healthcare issues will affect the healthcare marketplace and pharma in particular; what brands are doing in response to digital therapeutics in 2020; what’s on the horizon for marketing technology; how brands can optimize and maximize sales team effectiveness; and the skills and offerings brand managers will expect from their marketing agency partners this year.

Read the entire Q&A here.